ABO |
AS |
NT |
|||
O |
41.5-47.1% (44.3%) |
43.0-49.4% (46.2%) |
|||
A |
33.6-39.0% (36.3%) |
31.9-38.1% (35.0%) |
|||
B |
9.6-13.1% (11.3%) |
9.3-13.4% (11.3%) |
|||
AB |
6.5-9.5% (8.0%) |
5.8-9.2% (7.5%) |
ABO |
AS |
NT |
|||
O |
42.1-47.7% (44.9%) |
42.7-49.5% (46.1%) |
|||
A |
33.5-39.0% (36.2%) |
32.2-38.7% (35.4%) |
|||
B |
9.3-12.9% (11.1%) |
9.5-13.9% (11.7%) |
|||
AB |
6.2-9.3% (7.8%) |
5.1-8.5% (6.8%) |
ABO |
AS |
NT |
|||
O |
12.1-40.5% (26.3%) |
36.9-57.6% (47.3%) |
|||
A |
23.7-55.2% (39.5%) |
21.2-40.3% (30.8%) |
|||
B |
5.9-30.9% (18.4%) |
2.2-13.2% (7.7%) |
|||
AB |
4.0-27.5% (15.8%) |
7.1-21.5% (14.3%) |